Transport of molecules, particles, and cells in solid tumors.

Extraordinary advances in molecular biology and biotechnology have led to the development of a vast number of therapeutic anti-cancer agents. To reach cancer cells in a tumor, a blood-borne therapeutic molecule, particle, or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium, which it then must migrate through. Unfortunately, tumors often develop in ways that hinder these steps. The goal of research in this area is to analyze each of these steps experimentally and theoretically and integrate the resulting information into a unified theoretical framework. This paradigm of analysis and synthesis has fostered a better understanding of physiological barriers in solid tumors and aided in the development of novel strategies to exploit and/or overcome these barriers for improved cancer detection and treatment.

[1]  R. Jain,et al.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.

[2]  R K Jain,et al.  Vascular permeability in a human tumour xenograft: molecular charge dependence , 2000, British Journal of Cancer.

[3]  R K Jain,et al.  Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. , 1999, Cancer research.

[4]  R K Jain,et al.  Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. , 1999, Biophysical journal.

[5]  R. Jain,et al.  Effect of local anti-VEGF antibody treatment on tumor microvessel permeability. , 1999, Microvascular research.

[6]  A. Fischman,et al.  Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Jain,et al.  In vitro and in vivo quantification of adhesion between leukocytes and vascular endothelium. , 1999, Methods in molecular medicine.

[8]  R K Jain,et al.  Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice. , 1998, Cancer research.

[9]  R. K. Jain,et al.  Intratumoral infusion of fluid: estimation of hydraulic conductivity and implications for the delivery of therapeutic agents. , 1998, British Journal of Cancer.

[10]  P. Carmeliet,et al.  Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .

[11]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[12]  R. Jain,et al.  Cancer, angiogenesis and fractals , 1998, Nature Medicine.

[13]  R K Jain,et al.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[15]  R K Jain,et al.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.

[16]  R. Jain,et al.  Mice Lacking E‐Selection Show Normal Numbers of Rolling Leukocytes but Reduced Leukocyte Stable Arrest on Cytokine‐Activated Microvascular Endothelium , 1998, Microcirculation.

[17]  R. Jain The next frontier of molecular medicine: Delivery of therapeutics , 1998, Nature Medicine.

[18]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Jain,et al.  Delivery of Molecular and Cellular Medicine to Solid Tumors , 1997, Advanced drug delivery reviews.

[20]  R. Jain,et al.  Tumor pretargeting for radioimmunodetection and radioimmunotherapy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  R. Jain,et al.  Fractal Characteristics of Tumor Vascular Architecture During Tumor Growth and Regression , 1997, Microcirculation.

[22]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[23]  R K Jain,et al.  Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. , 1997, The American journal of pathology.

[24]  Paolo A. Netti,et al.  Solid stress inhibits the growth of multicellular tumor spheroids , 1997, Nature Biotechnology.

[25]  R. Jain,et al.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.

[26]  R. Jain,et al.  Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  R K Jain,et al.  Direct in vivo measurement of targeted binding in a human tumor xenograft. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Skalak,et al.  Macro- and Microscopic Fluid Transport in Living Tissues: Application to Solid Tumors , 1997 .

[29]  R. Jain,et al.  Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. , 1997, Microvascular research.

[30]  R K Jain,et al.  Geometric Resistance and Microvascular Network Architecture of Human Colorectal Carcinoma , 1997, Microcirculation.

[31]  R. Jain,et al.  Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  G. Palade,et al.  Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.

[33]  R. Jain,et al.  Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. , 1997, The American journal of pathology.

[34]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[35]  R. K. Jain,et al.  Interstitial fluid pressure in intracranial tumours in patients and in rodents. , 1997, British Journal of Cancer.

[36]  R K Jain,et al.  Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Jain,et al.  Perfusion of Single Tumor Microvessels: Application to Vascular Permeability Measurement , 1996, Microcirculation.

[38]  R. Jain,et al.  Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems. , 1996, Biophysical journal.

[39]  R. Jain,et al.  Fluorescence ratio imaging of interstitial pH in solid tumours: effect of glucose on spatial and temporal gradients. , 1996, British Journal of Cancer.

[40]  R K Jain,et al.  Tumor angiogenesis and interstitial hypertension. , 1996, Cancer research.

[41]  R. Jain,et al.  During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.

[42]  R. Jain,et al.  Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. , 1996, Cancer research.

[43]  Stuart K Williams,et al.  Effects of basic fibroblast growth factor on human microvessel endothelial cell migration on collagen I correlates inversely with adhesion and is cell density dependent , 1996, Journal of cellular physiology.

[44]  R. K. Jain,et al.  Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts. , 1996, British Journal of Cancer.

[45]  R K Jain,et al.  Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation. , 1996, Biophysical journal.

[46]  R K Jain,et al.  Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. , 1996, Microvascular research.

[47]  L. R. Manning,et al.  Oxygenation in tumors by modified hemoglobins , 1996, Journal of surgical oncology.

[48]  R. Jain,et al.  Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. , 1996, Microvascular research.

[49]  R. Jain,et al.  Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. , 1996, Microvascular research.

[50]  R. Jain,et al.  Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. , 1996, Cancer research.

[51]  R K Jain,et al.  Delivery of Molecular Medicine to Solid Tumors , 1996, Science.

[52]  R K Jain,et al.  Hindered diffusion in agarose gels: test of effective medium model. , 1996, Biophysical journal.

[53]  R. Jain,et al.  Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[54]  R. Jain,et al.  Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data. , 1996, British Journal of Cancer.

[55]  David A. Berk,et al.  Transport in Lymphatic Capillaries: II. Microscopic Velocity Measurement with Fluorescence Recovery After Photobleaching , 1996 .

[56]  R. Jain,et al.  Adhesion of activated natural killer cells to tumor necrosis factor-alpha-treated endothelium under physiological flow conditions. , 1996, Natural immunity.

[57]  R K Jain,et al.  Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. , 1996, The American journal of physiology.

[58]  R. Jain,et al.  Leukocyte rolling increases with age. , 1995, Blood.

[59]  R. Skalak,et al.  Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. , 1995, Cancer research.

[60]  R K Jain,et al.  Selectin- and integrin-mediated T-lymphocyte rolling and arrest on TNF-alpha-activated endothelium: augmentation by erythrocytes. , 1995, Biophysical journal.

[61]  R K Jain,et al.  Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. , 1995, Microvascular research.

[62]  I. Fidler,et al.  Modulation of the organ microenvironment for treatment of cancer metastasis. , 1995, Journal of the National Cancer Institute.

[63]  R. Jain,et al.  Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. , 1995, Cancer research.

[64]  R. Jain,et al.  Rolling in P-selectin-deficient mice is reduced but not eliminated in the dorsal skin. , 1995, Blood.

[65]  R K Jain,et al.  Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model. , 1995, Cancer research.

[66]  R. Jain,et al.  Kinetics of adhesion molecule expression and spatial organization using targeted sampling fluorometry. , 1995, BioTechniques.

[67]  Berk,et al.  Scale-invariant behavior and vascular network formation in normal and tumor tissue. , 1995, Physical review letters.

[68]  R. Jain,et al.  Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors. , 1995, Microvascular research.

[69]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[70]  A. Ullrich,et al.  Suppression of tumor growth in vivo by local and systemic 90K level increase. , 1995, Cancer research.

[71]  R. Jain,et al.  Interaction of activated natural killer cells with normal and tumor vessels in cranial windows in mice. , 1995, Microvascular research.

[72]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[73]  R K Jain,et al.  Diffusion and partitioning of proteins in charged agarose gels. , 1995, Biophysical journal.

[74]  Rakesh K. Jain,et al.  Spatial Heterogeneity in Tumor Perfusion Measured with Functional Computed Tomography at 0.05 µl Resolution , 1994 .

[75]  R. Jain,et al.  Tissue-isolated human tumor xenografts in athymic nude mice. , 1994, Microvascular research.

[76]  R K Jain,et al.  Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. , 1994, Cancer research.

[77]  R K Jain,et al.  Flow velocity in the superficial lymphatic network of the mouse tail. , 1994, The American journal of physiology.

[78]  R. Jain,et al.  Reduction of rigidity in human activated natural killer cells by thioglycollate treatment. , 1994, Journal of immunological methods.

[79]  R K Jain,et al.  A method for labeling cells for positron emission tomography (PET) studies. , 1994, Journal of immunological methods.

[80]  H. Nagawa,et al.  Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte. , 1994, Cancer research.

[81]  R K Jain,et al.  Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.

[82]  R. Jain,et al.  Angiogenesis and growth of isografted bone: quantitative in vivo assay in nude mice. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[83]  R K Jain,et al.  Analysis of cell flux in the parallel plate flow chamber: implications for cell capture studies. , 1994, Biophysical journal.

[84]  R K Jain,et al.  Barriers to drug delivery in solid tumors. , 1994, Scientific American.

[85]  R. Jain,et al.  Effect of hemodilution and resuscitation on tumor interstitial fluid pressure, blood flow, and oxygenation. , 1994, Microvascular research.

[86]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[87]  R K Jain,et al.  Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. , 1994, Cancer research.

[88]  M Intaglietta,et al.  Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Jain,et al.  Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. , 1994, British Journal of Cancer.

[90]  R. Jain,et al.  Residence time distributions of various tracers in tumors: implications for drug delivery and blood flow measurement. , 1994, Journal of the National Cancer Institute.

[91]  R. Jain,et al.  Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster. , 1994, British Journal of Cancer.

[92]  Rakesh K. Jain,et al.  Transport Phenomena in Tumors , 1994 .

[93]  R. Jain,et al.  Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors. , 1993, Cancer research.

[94]  R K Jain,et al.  Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. , 1993, Biophysical journal.

[95]  R. Jain,et al.  Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. , 1993, Cancer research.

[96]  R K Jain,et al.  Fluorescence ratio imaging measurement of pH gradients: calibration and application in normal and tumor tissues. , 1993, Microvascular research.

[97]  R. Jain,et al.  Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure. , 1993, Cancer research.

[98]  J. Gamble,et al.  Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. , 1993, Journal of immunology.

[99]  D. Longo,et al.  Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. , 1993, Cancer research.

[100]  R. Jain,et al.  Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.

[101]  R. Jain,et al.  Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31P NMR. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Jain,et al.  Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.

[103]  R K Jain,et al.  Interstitial hypertension in human breast and colorectal tumors. , 1992, Cancer research.

[104]  R. Jain,et al.  2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. , 1992, Cancer research.

[105]  E. N. Kaufman,et al.  In vitro measurement and screening of monoclonal antibody affinity using fluorescence photobleaching. , 1992, Journal of immunological methods.

[106]  R. Jain,et al.  Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: comparison with experimental data. , 1992, Cancer research.

[107]  J. Weinstein,et al.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. , 1992, Cancer research.

[108]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[109]  R K Jain,et al.  Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays. , 1992, Cancer research.

[110]  R. Jain,et al.  Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. , 1992, Cancer research.

[111]  K Messmer,et al.  Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. , 1992, Cancer research.

[112]  R. Jain,et al.  Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. , 1992, Cancer research.

[113]  R K Jain,et al.  Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. , 1991, Cancer research.

[114]  R K Jain,et al.  Interstitial hypertension in superficial metastatic melanomas in humans. , 1991, Cancer research.

[115]  E. N. Kaufman,et al.  Measurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regime. , 1991, Biophysical journal.

[116]  R. Jain,et al.  Pharmacokinetic analysis of two-step approaches using bifunctional and enzyme-conjugated antibodies. , 1991, Cancer research.

[117]  R. Jain,et al.  Effect of red blood cell rigidity on tumor blood flow: increase in viscous resistance during hyperglycemia. , 1991, Cancer research.

[118]  R. Jain,et al.  Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. , 1991, Journal of the National Cancer Institute.

[119]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution. , 1991, Microvascular research.

[120]  R. Jain,et al.  Interleukin 2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. , 1991, Cancer research.

[121]  J. Gamble,et al.  Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1. , 1991, Journal of immunology.

[122]  R. Jain,et al.  Measurement of capillary filtration coefficient in a solid tumor. , 1991, Cancer research.

[123]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. , 1991 .

[124]  R. Jain,et al.  Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.

[125]  R K Jain,et al.  Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications. , 1990, Biophysical journal.

[126]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics. , 1990, Microvascular research.

[127]  R K Jain,et al.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.

[128]  R K Jain,et al.  Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. , 1990, Journal of the National Cancer Institute.

[129]  R. Jain,et al.  Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. , 1989, Cancer research.

[130]  R K Jain,et al.  Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[131]  R K Jain,et al.  Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. , 1989, Cancer research.

[132]  R. Jain,et al.  Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. , 1989, Cancer research.

[133]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.

[134]  R K Jain,et al.  Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.

[135]  J. Gamble,et al.  Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta. , 1988, Science.

[136]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[137]  R. Jain,et al.  Response of tumours to hyperglycaemia: characterization, significance and role in hyperthermia. , 1988, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[138]  R. Jain,et al.  Blood flow and venous pH of tissue-isolated Walker 256 carcinoma during hyperglycemia. , 1988, Cancer research.

[139]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[140]  B. Haraldsson,et al.  Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations. , 1987, Acta physiologica Scandinavica.

[141]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[142]  R. K. Jain,et al.  Effect of glucose and galactose on red blood cell membrane deformability. , 1987, International journal of microcirculation, clinical and experimental.

[143]  R. Jain,et al.  Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.

[144]  R. Jain,et al.  Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. , 1985, International journal of microcirculation, clinical and experimental.

[145]  R. Jain,et al.  Tumor Blood Flow-Characterization, Modifications, and Role in Hyperthermia , 1984, IEEE Transactions on Sonics and Ultrasonics.

[146]  R. Jain,et al.  Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. , 1984, Journal of the National Cancer Institute.

[147]  R K Jain,et al.  Differential response of normal and tumor microcirculation to hyperthermia. , 1984, Cancer research.

[148]  R K Jain,et al.  Extravascular diffusion in normal and neoplastic tissues. , 1984, Cancer research.

[149]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[150]  R. Jain,et al.  Microcirculatory flow changes during tissue growth. , 1983, Microvascular research.

[151]  R K Jain,et al.  Dynamics of neovascularization in normal tissue. , 1981, Microvascular research.

[152]  R. Jain Transient Temperature Distributions in an Infinite, Perfused Medium due to a Time-Dependent, Spherical Heat Source , 1979 .

[153]  M Intaglietta,et al.  Tissue perfusion inhomogeneity during early tumor growth in rats. , 1979, Journal of the National Cancer Institute.

[154]  R. Jain Effect of Inhomogeneities and Finite Boundaries on Temperature Distributions in a Perfused Medium, With Application to Tumors , 1978 .

[155]  R. Jain,et al.  Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man. , 1978, The American journal of physiology.

[156]  P. Gullino,et al.  Diffusion and convection in normal and neoplastic tissues. , 1974, Cancer research.